BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Prostate, Neocentromeres, Acetaminophen, rs2230926, DRD2, T cell differentiation)
Bookmark Forward

QuickView for raltegravir (compound)


Genetic Markers

Most Correlated Genes

  1. No genes found
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. No biogroups found
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Total, Unbound, Renal, and Hepatic Clearances of Raltegravir and the Formation and Elimination Clear…
  2. Efficacy and safety of raltegravir plus lamivudine maintenance therapy.
  3. Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamic…
  4. Optimising neonatal antiretroviral therapy using raltegravir: a qualitative analysis of healthcare w…
  5. Effects of raltegravir formulation change on medication adherence and medication errors.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. The Effect of Rifapentine on Raltegravir
  2. Raltegravir for HAM/TSP
  3. Effect of Antacids on the Pharmacokinetics of Raltegravir
  4. Levels of Raltegravir in the Female Genital Tissue
  5. Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.